Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Other Non-Current Liabilities (2016 - 2022)

Historic Other Non-Current Liabilities for Prothena Corp Public (PRTA) over the last 8 years, with Q4 2022 value amounting to $553000.0.

  • Prothena Corp Public's Other Non-Current Liabilities changed 0.0% to $553000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $553000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $553000.0 for FY2022, which is 0.0% changed from last year.
  • As of Q4 2022, Prothena Corp Public's Other Non-Current Liabilities stood at $553000.0, which was down 0.0% from $553000.0 recorded in Q3 2022.
  • Over the past 5 years, Prothena Corp Public's Other Non-Current Liabilities peaked at $553000.0 during Q3 2018, and registered a low of $553000.0 during Q3 2018.
  • Over the past 5 years, Prothena Corp Public's median Other Non-Current Liabilities value was $553000.0 (recorded in 2018), while the average stood at $553000.0.
  • The largest annual percentage gain for Prothena Corp Public's Other Non-Current Liabilities in the last 5 years was 0.0% (2019), contrasted with its biggest fall of 0.0% (2019).
  • Prothena Corp Public's Other Non-Current Liabilities (Quarter) stood at $553000.0 in 2018, then changed by 0.0% to $553000.0 in 2019, then changed by 0.0% to $553000.0 in 2020, then changed by 0.0% to $553000.0 in 2021, then changed by 0.0% to $553000.0 in 2022.
  • Its last three reported values are $553000.0 in Q4 2022, $553000.0 for Q3 2022, and $553000.0 during Q2 2022.